Milestone Pharmaceuticals reported cash from operations of -$22.71M and free cash flow of -$22.74M for the quarter ended Jun 2026, down 80.8% year over year. This cash flow statement covers 34 quarters of results from Mar 2018 through Jun 2026, standardized by Business Quant from the company’s SEC filings.
| Cash Flow Statement | Mar2018 | Jun2018 | Sep2018 | Dec2018 | Mar2019 | Jun2019 | Sep2019 | Dec2019 | Mar2020 | Jun2020 | Sep2020 | Dec2020 | Mar2021 | Jun2021 | Sep2021 | Dec2021 | Mar2022 | Jun2022 | Sep2022 | Dec2022 | Mar2023 | Jun2023 | Sep2023 | Dec2023 | Mar2024 | Jun2024 | Sep2024 | Dec2024 | Mar2025 | Jun2025 | Sep2025 | Dec2025 | Mar2026 | Jun2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities | ||||||||||||||||||||||||||||||||||
| Net Income | -14.22M | -16.88M | -16.65M | -14.56M | ||||||||||||||||||||||||||||||
| Share-based CompensationStock Comp. | 17.30M | 1.98M | 20.60M | 19.00M | 18.60M | 2.14M | 17.70M | 16.20M | 13.20M | 1.88M | 8.60M | 8.15M | 8.74M | 1.47M | 11.13M | 11.28M | 11.10M | 3.55M | 13.15M | 13.92M | ||||||||||||||
| Cash from OperationsCash from Ops. | -9.39M | -12.38M | -13.95M | -14.09M | -11.57M | -12.86M | -13.90M | -10.56M | -12.16M | -9.80M | -8.93M | -6.05M | -7.02M | -6.84M | -13.95M | -12.57M | -9.75M | -12.78M | -16.05M | -22.71M | ||||||||||||||
| Depreciation, Depletion & Amortization | ||||||||||||||||||||||||||||||||||
| Amortization of Deferred ChargesAmort. Deferred Charges | 0.06M | 0.06M | 0.08M | 0.09M | 0.09M | 0.10M | 0.10M | 0.10M | 0.11M | 0.11M | 0.12M | 0.12M | 0.12M | |||||||||||||||||||||
| Depreciation & Amortization (CF)Dep. & Amort. | 0.02M | 0.02M | 0.02M | 0.02M | 0.03M | 0.01M | 0.02M | 0.02M | 0.02M | 0.03M | 0.03M | 0.03M | 0.03M | 0.03M | 0.03M | 0.03M | 0.03M | 0.03M | 0.06M | 0.06M | ||||||||||||||
| Change in Working Capital | ||||||||||||||||||||||||||||||||||
| Change in ReceivablesChange Receivables | 1.60M | 1.11M | ||||||||||||||||||||||||||||||||
| Change in InventoryChange Inventory | 1.18M | 2.90M | ||||||||||||||||||||||||||||||||
| Change in Account PayablesChange Payables | 0.45M | 0.54M | 4.38M | -1.57M | ||||||||||||||||||||||||||||||
| Change in Accured ExpensesChange Accured Exp. | 0.52M | 0.96M | -2.14M | -0.33M | 1.95M | -0.39M | -0.91M | 1.55M | 1.30M | -0.90M | -3.43M | 0.75M | 0.68M | 2.88M | 4.41M | -4.20M | 2.27M | 1.95M | 1.84M | 2.43M | ||||||||||||||
| Change in TaxesChange Taxes | ||||||||||||||||||||||||||||||||||
| Investing Activities | ||||||||||||||||||||||||||||||||||
| Capital ExpendituresCapex | 0.10M | 0.11M | 0.03M | 0.03M | 0.02M | 0.03M | 0.00M | 0.02M | 0.01M | 0.01M | 0.00M | 0.28M | 0.04M | 0.03M | ||||||||||||||||||||
| Change in Acquisitions & DivestmentsChange Acquisitions | 34.47M | 10.00M | ||||||||||||||||||||||||||||||||
| Cash from Investing ActivitiesCash from Investing | 23.00M | 15.00M | -8.00M | -15.06M | -17.05M | -17.02M | 29.97M | -28.03M | -10.86M | 13.68M | -27.01M | 9.48M | 6.48M | 19.33M | 33.58M | 9.94M | -34.98M | 2.70M | -80.03M | 111.99M | ||||||||||||||
| Financing Activities | ||||||||||||||||||||||||||||||||||
| Other financing activitiesOther financing | 0.02M | 0.08M | 0.05M | 0.14M | 0.03M | 0.20M | 0.13M | 0.02M | 0.24M | 0.12M | 0.07M | 0.14M | 0.16M | 0.14M | 8.29M | 9.12M | ||||||||||||||||||
| Cash from Financing ActivitiesCash from Financing | 0.02M | 0.09M | 0.05M | 0.14M | 2.67M | 0.23M | 50.25M | -2.77M | 0.30M | 0.00M | 32.32M | -0.30M | 0.07M | 0.02M | 0.14M | 0.04M | 48.92M | 36.43M | 94.35M | 9.13M | ||||||||||||||
| Change in Capital Stock | ||||||||||||||||||||||||||||||||||
| Net Shares Issued and RepurchasedNet Shares Issued | 1.39M | 1.79M | 1.49M | 1.88M | 0.39M | 1.65M | 1.15M | 1.53M | 2.13M | |||||||||||||||||||||||||
| Net Equity Issued and RepurchasedNet Equity Issued | -0.01M | 27.54M | -0.28M | 14.45M | 10.89M | |||||||||||||||||||||||||||||
| Additional items | ||||||||||||||||||||||||||||||||||
| Change in Cash | 13.63M | 2.71M | -21.90M | -29.00M | -25.95M | -29.65M | 66.32M | -41.36M | -22.71M | 3.88M | -3.63M | 3.13M | -0.46M | 12.52M | 19.77M | -2.59M | 4.19M | 26.36M | -1.73M | 98.41M | ||||||||||||||
| Free Cash FlowFCF | -9.39M | -12.38M | -13.95M | -14.09M | -11.68M | -12.97M | -13.94M | -10.60M | -12.18M | -9.83M | -8.93M | -6.05M | -7.02M | -6.87M | -13.96M | -12.58M | -9.75M | -13.06M | -16.10M | -22.74M | ||||||||||||||
| Net Cash FlowNCF | 13.63M | 2.71M | -21.90M | -29.00M | -25.95M | -29.65M | 66.32M | -41.36M | -22.71M | 3.88M | -3.63M | 3.13M | -0.46M | 12.52M | 19.77M | -2.59M | 4.19M | 26.36M | -1.73M | 98.41M |